{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:11Z","timestamp":1791323651953,"version":"4.3.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jceh.2026.103615","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:28:47Z","timestamp":1784071727000},"page":"103615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management Strategies and Clinical Outcomes in Steroid-resistant Rejection after Liver Transplantation: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"V.U.","family":"Lakshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Narmadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sudhindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair U.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103615_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103615_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.12688\/f1000research.162481.1","article-title":"Donor-derived circulating cell-free DNA as a rejection biomarker and modulator of immunosuppression following liver transplantation: a randomized controlled trial","volume":"14","author":"Lakshmi","year":"2025","journal-title":"F1000Res"},{"key":"10.1016\/j.jceh.2026.103615_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2024.07.203","article-title":"Risk factors for steroid-resistant rejection following live donor liver transplantation","volume":"26","author":"Sudhindran","year":"2024","journal-title":"HPB"},{"key":"10.1016\/j.jceh.2026.103615_bib4","first-page":"156","article-title":"Current status of diagnosis and treatment of steroid-resistant acute rejection after liver transplantation","volume":"16","author":"Peng","year":"2025","journal-title":"Organ Transplant"},{"key":"10.1016\/j.jceh.2026.103615_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.52604\/alt.23.0021","article-title":"Biological immunosuppressive agents used in liver transplantation","volume":"3","author":"Park","year":"2023","journal-title":"Ann Liver Transplant"},{"key":"10.1016\/j.jceh.2026.103615_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.transproceed.2020.01.013","article-title":"Analysis of immune cell repopulation after anti-thymocyte globulin administration for steroid-resistant T-cell-mediated rejection","volume":"52","author":"Sim","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2026.103615_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cld.2024.12.006","article-title":"Immunosuppression post-liver transplant: end of the calcineurin era?","volume":"29","author":"Yataco","year":"2025","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2026.103615_bib8","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/TXD.0000000000000604","article-title":"Rituximab in combination with bortezomib, plasmapheresis, and high-dose IVIG to treat antibody-mediated renal allograft rejection","volume":"2","author":"Waiser","year":"2016","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jceh.2026.103615_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5604\/01.3001.0012.2246","article-title":"Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: a single-center study","volume":"19","author":"Hashim","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2026.103615_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1499-3872(14)60260-5","article-title":"Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials","volume":"13","author":"Deng","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"6 Pt 2","key":"10.1016\/j.jceh.2026.103615_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1399-0012.1996.tb00765.x","article-title":"Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation","volume":"10","author":"Clavien","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2026.103615_bib12","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s12072-024-10703-4","article-title":"Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group","volume":"18","author":"Manzia","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2026.103615_bib13","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2026.103615_bib14","series-title":"Cochrane. Review Manager (RevMan) [computer program]. Version 7.12.0","year":"2024"},{"key":"10.1016\/j.jceh.2026.103615_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: r as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jceh.2026.103615_bib16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archsurg.1987.01400220030004","article-title":"A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection","volume":"122","author":"Colonna","year":"1987","journal-title":"Arch Surg"},{"key":"10.1016\/j.jceh.2026.103615_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.transproceed.2021.10.019","article-title":"Steroid-resistant rejection in liver transplant: a single-center study for risk factors and second-line treatment","volume":"54","author":"Lee","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2026.103615_bib18","first-page":"172","article-title":"Steroid-resistant acute rejections after liver transplant","volume":"8","author":"Aydogan","year":"2010","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jceh.2026.103615_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clinre.2014.04.005","article-title":"Steroid-resistant acute rejection after cadaveric liver transplantation: experience from a single center","volume":"38","author":"Wu","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103615_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s002689900160","article-title":"Management of acute steroid-resistant rejection after liver transplantation","volume":"20","author":"Platz","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.jceh.2026.103615_bib21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00007890-199605150-00014","article-title":"Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection","volume":"61","author":"Millis","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2026.103615_bib22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/petr.12373","article-title":"Basiliximab treatment for steroid-resistant rejection in pediatric patients following liver transplantation for acute liver failure","volume":"18","author":"Shigeta","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jceh.2026.103615_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.TP.0000054682.53834.EA","article-title":"Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transplant recipients: a preliminary experience","volume":"75","author":"Aw","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2026.103615_bib24","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1016\/j.transproceed.2005.10.022","article-title":"Anti-interleukin-2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation","volume":"37","author":"Orr","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2026.103615_bib25","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1016\/j.transproceed.2018.09.001","article-title":"Anti-thymocyte globulin use for corticosteroid-nonresponsive rejection after liver transplantation","volume":"50","author":"Palmer","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2026.103615_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.transproceed.2017.11.008","article-title":"Antibody drug treatment for steroid-resistant rejection after pediatric living donor liver transplantation: a single-center experience","volume":"50","author":"Hirata","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2026.103615_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1620\/tjem.208.225","article-title":"Usage of deoxyspergualin on steroid-resistant acute rejection in living donor liver transplantation","volume":"208","author":"Kawagishi","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jceh.2026.103615_bib28","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:44:37Z","timestamp":1791323077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0973688326001477"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103615","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management Strategies and Clinical Outcomes in Steroid-resistant Rejection after Liver Transplantation: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103615"}}